Avidity Partners Management LP Syndax Pharmaceuticals Inc Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

A detailed history of Avidity Partners Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Avidity Partners Management LP holds 2,455,000 shares of SNDX stock, worth $41 Million. This represents 2.9% of its overall portfolio holdings.

Number of Shares
2,455,000
Previous 3,335,000 26.39%
Holding current value
$41 Million
Previous $68.5 Million 30.98%
% of portfolio
2.9%
Previous 3.37%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.93 - $24.81 $15.8 Million - $21.8 Million
-880,000 Reduced 26.39%
2,455,000 $47.3 Million
Q2 2024

Aug 14, 2024
BUY
$18.82 - $23.79 $17.4 Million - $21.9 Million
922,500 Added 38.24%
3,335,000 $68.5 Million
Q1 2024

May 15, 2024
SELL
$19.71 - $24.57 $30.3 Million - $37.8 Million
-1,537,500 Reduced 38.92%
2,412,500 $57.4 Million
Q4 2023

Feb 14, 2024
BUY
$11.39 - $21.67 $12.9 Million - $24.5 Million
1,129,000 Added 40.02%
3,950,000 $85.4 Million
Q3 2023

Nov 14, 2023
SELL
$14.52 - $21.77 $740,520 - $1.11 Million
-51,000 Reduced 1.78%
2,821,000 $41 Million
Q2 2023

Aug 14, 2023
SELL
$19.35 - $22.31 $19.2 Million - $22.2 Million
-993,300 Reduced 25.7%
2,872,000 $60.1 Million
Q1 2023

May 15, 2023
SELL
$20.66 - $28.98 $41.2 Million - $57.8 Million
-1,995,700 Reduced 34.05%
3,865,300 $81.6 Million
Q4 2022

Feb 14, 2023
BUY
$20.64 - $26.24 $5.66 Million - $7.19 Million
274,100 Added 4.91%
5,861,000 $149 Million
Q3 2022

Nov 14, 2022
BUY
$18.51 - $24.79 $2.53 Million - $3.39 Million
136,900 Added 2.51%
5,586,900 $134 Million
Q2 2022

Aug 15, 2022
BUY
$13.64 - $19.48 $8.55 Million - $12.2 Million
626,600 Added 12.99%
5,450,000 $105 Million
Q3 2021

Nov 15, 2021
BUY
$13.87 - $19.8 $2.89 Million - $4.13 Million
208,400 Added 4.52%
4,823,400 $92.2 Million
Q2 2021

Aug 16, 2021
BUY
$13.42 - $25.18 $10.3 Million - $19.4 Million
769,000 Added 19.99%
4,615,000 $79.2 Million
Q1 2021

May 17, 2021
BUY
$19.28 - $24.59 $10.4 Million - $13.2 Million
538,000 Added 16.26%
3,846,000 $86 Million
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $22 Million - $38.4 Million
1,453,900 Added 78.42%
3,308,000 $73.6 Million
Q3 2020

Nov 16, 2020
BUY
$13.39 - $17.48 $4.37 Million - $5.71 Million
326,700 Added 21.39%
1,854,100 $27.4 Million
Q2 2020

Aug 14, 2020
BUY
$8.94 - $20.98 $13.7 Million - $32 Million
1,527,400 New
1,527,400 $22.6 Million

Others Institutions Holding SNDX

# of Institutions
228
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $945M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email